Theresa Feehan

PFD Report Partially Responded Ref: 2019-0070
Date of Report 27 February 2019
Coroner Fiona Wilcox
Response Deadline est. 4 August 2019
Coroner's Concerns (AI summary)
The practice's medication review system was inadequate, with outdated patient records and poor correlation between problem lists and prescribed drugs. This led to dangerous medications being continued and a lack of proper rationale for prescribing.
View full coroner's concerns
That the system of medication review within the practice is inadequate putting patients at risk.
Responses
CQC Regulator / Inspectorate
20 Jan 2020
Noted
The CQC conducted inspections of Lisson Grove Health Centre but ultimately did not find concerns in the areas identified in the prevention of future death report. They rated the health centre 'Good' overall. (AI summary)
View full response
Dear HM Coroner

Prevention of future death report following inquest into the death of Mrs Theresa Margaret Feehan On 24 April 2019 we wrote to you in response to your prevention of future death report issued following the death of Mrs Theresa Margaret Feehan.

In our response we provided provisional information following our focused inspection of Lisson Grove Health Centre in March 2019. This inspection had been triggered by the concerns raised in your prevention of future death report. We made clear in our letter the findings were at draft stage and the provider had not at that stage had an opportunity to challenge the findings, in line with our fairness obligations under the public law principles. I am now writing to update you.

The provider made significant challenges to the findings we made. We accepted those challenges and decided there was no basis for us to take enforcement action. We also carried out a full and comprehensive rated inspection in June 2019. I attach copies of the reports of both of these inspections. They are also available on our website under the “All reports” link at https://www.cqc.org.uk/location/1-549237033.

As you will see, we ultimately did not find concerns in the areas identified in the prevention of future death report. We rated Lisson Grove Health Centre ‘Good’ overall, with a few areas to address in relation to childhood immunisations and cervical screening.

I hope this information is helpful and updates and clarifies our findings after the inspections.

Should you need to contact me further about this matter you can contact me through our National Customer Service Centre using the details below: Care Quality Commission Citygate Gallowgate Newcastle upon Tyne NE1 4PA

Telephone: 03000 616161 Fax: 03000 616171

Telephone: 03000 616161

Email: enquiries@CQC.org.uk

Write to: Care Quality Commission Citygate Gallowgate Newcastle upon Tyne NE1 4PA

it would be helpful if you could include the reference number ENQ1-8222217545.
Sent To
  • Care Quality Commission
  • Lisson Grove Health Centre
Response Status
Linked responses 1 of 2
56-Day Deadline 4 Aug 2019
About PFD responses

Organisations named in PFD reports must respond within 56 days explaining what actions they are taking.

Source: Courts and Tribunals Judiciary

Report Sections
Investigation and Inquest
On the 15ih January 2019, evidence was heard touching the death of Theresa Margaret Feehan. Mrs Feehan had been found deceased at home on 12th March 2018. She was 58 years old at the time of her death. The findings of the court were as follows: Medical Cause of Death 1 (a) Aspiration Pneumonia (b) Ingestion of Amitriptyline and Dihydrocodeine when and where the deceased came by her death: Mrs Feehan suffered with oxygen and steroid dependant allergic asthma: This was subject to regular severe exacerbations She was also prescribed potentially respiratory compromising medication, including amitriptyline, clonazepam and chlorpheniramine. On the 10/3/2018 she saw her GP with a further severe exacerbation of her asthma. Dihydrocodeine was prescribed in an attempt to control her pleuritic pain and respiratory distress. She had recently been prescribed morphine in hospital On 12/3/2018 she was found at home deceased by her son, and found to have toxic levels of amitriptyline and dihydrocodeine which had contributed to her death in association with her underlying lung disease_ There was no evidence of suicidal intent nor suspicious findings. How,

Conclusion of the Coroner as to the death: Natural causes in combination with side effects of prescribed medication_ Circumstances of the Death_ During the evidence it became apparent that the active problem list on the GP records was out of date and missing many relevant; serious medical conditions. There was little correlation between the active problem list and list of prescribed medication_ Drugs potentially dangerous to Mrs Feehan because of their respiratory depressant effects, especially when combined with other medication, such as clonazepam which had originally apparently been prescribed for restless legs, had been continued without challenge despite Mrs Feehan having had medication reviews There was no proper recording of the reason or rationale for the dose of amitriptyline that she was taking: It was not even recorded on the active problem list that she was on home oxygen_ Requests for information from the practice by the court had been managed by administrative staff and not properly responded to despite the eventual service of two summonses. This raised the concern in the evidence that other patients may have their notes and prescribing properly reviewed and that admin staff may be undertaking tasks without proper supervision such that other clinical issues may arise and go unrecognised. The evidence suggested that the practice doctors appeared to assume that as Mrs Feehan was so often admitted to hospital her repeat medications were being reviewed by the hospital: Concerns of the Coroner: That the system of medication review within the practice is inadequate putting patients at risk. That the recording and coding of relevant medical on the active problem list is inadequate thus putting patients at risk That there appears to be little correlation between the medication list and the active problem list such that it would make it difficult for a reviewing doctor to understand why a patient was on a particular medication and thus challenge its continuation or dosage appropriately, thus putting patients at risk That there appears to be no clear system for identifying medications which may interact to the detriment of the patient or no system to address such issues should they arise such as reducing or stopping redundant treatment thus putting patients at risk
5. That administration systems within the practice should be audited to determine whether they are adequate and the work of the administrative staff sufficiently supervised, such that patients are not put at risk:
Action Should Be Taken
In my opinion action should be taken to prevent future deaths and believe you [ANDIOR your organisation] have the power to take such action: It is for each addressee to respond to matters relevant to them_
Related Inquiry Recommendations

Public inquiry recommendations addressing similar themes

Healthcare trust risk information visibility
Southport Inquiry
Inaccurate and inaccessible patient records
Cabinet Office Leadership for Emergencies
COVID-19 Inquiry
Unqualified Staff Deployment
Pandemic Data Systems and Research
COVID-19 Inquiry
Unqualified Staff Deployment
UK-wide Expert Register
COVID-19 Inquiry
Unqualified Staff Deployment
Data Systems for High-Risk Individuals
COVID-19 Inquiry
Inaccurate and inaccessible patient records
Patient Records Audit
Infected Blood Inquiry
Inaccurate and inaccessible patient records
Foundation Doctors in Children's Wards
Hyponatraemia Inquiry
Unqualified Staff Deployment
Blood Test Result Documentation
Hyponatraemia Inquiry
Inaccurate and inaccessible patient records
Drug Prescription Documentation
Hyponatraemia Inquiry
Pharmacist missed drug contraindications
Recording Clinical Discussions
Hyponatraemia Inquiry
Inaccurate and inaccessible patient records

Data sourced from Courts and Tribunals Judiciary under the Open Government Licence.